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Jean-Emmanuel De La Coussaye2,3,4, Philippe J Bousquet2, Jean-Marie Robine2,5 and Jean Bousquet1,2,3Abstract
Background: Potentially avoidable hospitalizations represent an indirect measure of access to effective primary
care. However many approaches have been proposed to measure them and results may differ considerably. This
work aimed at examining the agreement between the Weissman and Ansari approaches in order to measure
potentially avoidable hospitalizations in France.
Methods: Based on the 2012 French national hospital discharge database (Programme de Médicalisation des
Systèmes d’Information), potentially avoidable hospitalizations were measured using two approaches proposed by
Weissman et al. and by Ansari et al. Age- and sex-standardised rates were calculated in each department. The two
approaches were compared for diagnosis groups, type of stay, severity, age, sex, and length of stay.
Results: The number and age-standardised rate of potentially avoidable hospitalizations estimated by the Weissman
et al. and Ansari et al. approaches were 742,474 (13.3 cases per 1,000 inhabitants) and 510,206 (9.0 cases per 1,000
inhabitants), respectively. There are significant differences by conditions groups, age, length of stay, severity level,
and proportion of medical stays between the Weissman and Ansari methods.
Conclusions: Regarding potentially avoidable hospitalizations in France in 2012, the agreement between the
Weissman and Ansari approaches is poor. The method used to measure potentially avoidable hospitalizations is
critical, and might influence the assessment of accessibility and performance of primary care.
Keywords: Diagnosis-related groups, International classification of disease, Potentially avoidable hospitalizations,
PMSI, FranceBackground
The concept of potentially avoidable hospitalizations
(PAH) or ambulatory care sensitive hospitalizations
(ACSH) was proposed as an indirect measure of access
to effective primary care [1-5]. It has also been used as a
marker of overall healthcare system performance [6,7].
This approach is appealing since a large number of
states, regions or hospitals have reliable data on hospital
discharges and limited data on ambulatory care [8].
Avoiding admission represents a substantial reduction in* Correspondence: g-mercier@chu-montpellier.fr
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unless otherwise stated.costs, enhances patients’ quality of life and is an issue of
considerable interest to policy makers and the public [9].
Higher rates of PAH are associated with socioeconomic
deprivation [10,11], poor accessibility to primary care
[5], and deficient continuity of care [12]. PAH can be re-
duced by programs aimed at improving primary care de-
livery [13,14] or by multifaceted interventions [15]. Thus
PAH rates might increase where access to GPs is lower
and where primary care is suboptimal.
In France, primary care is mostly delivered by self-
employed physicians in the ambulatory care sector. Gen-
eral Practitioners have been playing a semi gatekeeping
role since the late 1990s. Although patients are financially
incentivized to visit their GP before being referred to a
specialist, the gate-keeping procedure is not mandatory. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 PAH selection algorithm according to Weissman
et al. modified by Gusmano et al.
Category ICD-10 codes
(Principal diagnosis only)
Bacterial pneumonia J13, J14, J15, J16.0, J16.8, J18
Congestive heart failure I50
Asthma J45
Cellulitis J34.0, K12.2, L02, L03
Complications of peptic ulcer
disease
K25.0, K25.1, K25.2, K25.4, K25.5, K25.6,
K26.0, K26.1, K26.2, K26.4, K26.5, K26.6,
K27.0, K27.1, K27.2, K27.4, K27.5, K27.6,
K28.0, K28.1, K28.2, K28.4, K28.5, K28.6
Pyelonephritis N10, N11, N12, N13.6, N15.8, N15.9,
N17.2
Type 2 diabetes mellitus with
hyperosmolarity or coma
E10.0, E10.1, E11.0, E11.1, E13.0, E13.1,
E14.0, E14.1
Ruptured appendix K35.2, K35.3
Hypertension I10, I11.0, I11.9, I12.0, I12.9, I13.0, I13.1,
I13.2, I13.9, I15.0,I15.1, I15.2, I15.8, I15.9,
I67.4
Hypokalaemia E87.6
Immunizable conditions A35, A36, A37, A80, B05, B26
Gangrene I73.0, L88, I70.2
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in the lack of coordination and continuity of care between
GPs, ambulatory care and hospital care [16]. So far, GPs’
individual performance measures do not include PAH
rates.
There are significant disparities for PAH by ethnicity,
insurance status, and socioeconomic status [17]. PAH
are common in older people [18-20] but can occur at
any age [21-24]. Chronic diseases represent an important
cause of PAH [3]. Comorbidities are associated with
PAH [25].
Measuring PAH is important for policymakers and re-
searchers willing to assess the performance of the primary
care sector and to monitor the impact of interventions
aimed at improving access. Trends in PAH are available
for many countries [26-30] including France [31,32]. The
estimation of the proportion of PAH among all hospital
discharges is based on the assumption that hospitaliza-
tions for some conditions are preventable. Each of the
conditions is defined by a list of diagnosis codes from the
International Classification of Diseases (ICD). Two of the
most critical issues include the selection of categories of
conditions (diseases or complications of diseases) and
of the corresponding ICD codes. Therefore, different
methods have been used, that vary in terms of conditions
and ICD codes. In France, Gusmano et al. [31,32] used the
Weissman et al. approach [4], but this method does not
encompass all potentially avoidable conditions. As an
example, status asthmaticus, the most severe PAH in
asthma, is not coded (ICD10 code J46), whereas it is
coded in other studies [23]. Moreover, COPD (J20, J41,
J42, J43, J44, J47 [23]), the most common cause of death
due to respiratory diseases [33,34] and a common cause of
PAH [5], is not even considered by Weissman et al. [4].
The current study aimed at estimating PAH in France
in 2012 using the French hospital discharge database
(Programme de Médicalisation des Systèmes d’Informa-
tion; PMSI). Firstly, the Weissman et al. approach [4],
already tested in France, was compared with the more
recent Ansari one [23] at the French national and de-
partmental levels. ICD-10 codes were used exactly as
proposed by the authors.
Methods
Study population
The data for all patients hospitalized in France in 2012
were collected from the national administrative database,
the PMSI. French public and private hospitals are fi-
nanced through a Diagnosis-Related Group (DRG)-based
prospective payment system [35,36]. The PMSI is the
national discharge database and includes all hospital dis-
charges from all public and private hospitals in France.
The quality of this database is deemed well, especially
since 2007 [37]. It centralises data by a diagnosis that isencoded according to ICD-10, medical procedure, age,
residence and French diagnosis-related groups of patients
admitted to all hospitals (public and private). The reliabil-
ity and validity of the PMSI database have already been
demonstrated for various acute and chronic conditions
[38-41]. Hospital discharges are classified in diagnosis
groups (catégories majeures diagnostiques, CMD) and
then in DRGs according to ICD-10 principal and second-
ary diagnosis codes, surgical and non-surgical procedures
(Classification Commune des Actes Medicaux, CCAM)
[42] and age. We extracted discharge data for acute hos-
pital stays in medicine, surgery and obstetrics/gynaecol-
ogy. Discharges for foreign patients were excluded.
This research was approved by the Commission
Nationale Informatique et Liberte, an independent ethic
committee (www.cnil.fr; approval number DE-2013-118).
Access to the PMSI database is free for researchers after
approval by the CNIL. Written informed consent from pa-
tients is not required by French law for such studies.PAH definition
Since there is no consensus on the best one, two methods
were independently used to identify PAH among all hos-
pital discharges. Weissman et al. [4] (Table 1) was initially
used since this is the standard approach for French studies
[31,32]. In his seminal paper, Weissman used ICD-9 codes
(Weissman 1992). We have used both the original method
[4] and the ICD-10 conversion published by Gusmano
et al. [43]. Only principal diagnosis codes were considered.
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the latest review carried out by Rosano et al. [5]. There are
important missing diseases (e.g. Chronic Obstructive
Pulmonary Diseases, COPD) and the codes reported
may not be in full conformity with the current ICD-10
classification. We therefore used a second approach re-
cently published by Ansari et al. used to assess and moni-
tor access to primary care in Victoria, Australia [23]
(Table 2). The strength of this method is that it encom-
passes a broader range of conditions, including COPD.
For each method, any hospitalization with at least one
of the ICD codes was systematically identified as poten-
tially avoidable.
Hospitalizations were described using diagnosis-related
groups of patients (CMD) from the French DRG system
based on diagnosis codes (ICD-10) and surgical procedure
codes (CCAM). The CMDs represent the first step of the
classification algorithm. They are based on ICD-10 princi-
pal diagnosis codes [36].Table 2 PAH selection algorithm according to Ansari et al.
Category ICD-10 codes
Influenza and pneumonia J10, J11, J13, J14, J15.3, J15.4, J15.7,
Other vaccine preventable A35, A36, A37, A80, B05, B06, B16.1
B26, G00.0, M01.4
Asthma J45, J46
Congestive heart failure I50, I11.0, J81
Diabetes complications E10.1, E10.2, E10.3, E10.4, E10.5, E10
E11.1, E11.2, E11.3, E11.4, E11.5, E11
E13.1, E13.2, E13.3, E13.4, E13.5, E13
E14.1, E14.2, E14.3, E14.4, E14.5, E14
Chronic obstructive pulmonary disease J20, J41, J42, J43, J44, J47
Angina I20, I24.0, I24.8, I24.9
Iron deficiency anaemia D50.1, D50.8, D50.9
Hypertension I10, I11.9
Nutritional deficiencies E40, E41, E42, E43, E55.0, E64.3
Dehydration and gastroenteritis E86, K52.2, K52.8, K52.9
Pyelonephritis N39.0, N10, N12, N11, N13.6
Perforated/ bleeding ulcer K25.0, K25.1, K25.2, K25.4, K25.5, K25
K26.4, K26.5, K26.6, K27.0, K27.1, K27
K28.0, K28.1, K28.2, K28.4, K28.5, K28
Cellulitis L03, L04, L08, L98.0, L88, L98.3
Pelvic inflammatory disease N70, N73, N74
Ear, nose and throat infections H66, H67, J02, J03, J06, J31.2
Dental conditions K02, K03, K04, K05, K06, K08, K09.8,
Convulsions and epilepsy O15, G40, G41, R56
Gangrene R02Severity of disease was based on comorbidities, compli-
cations and age according to the French DRG grouping
system. Four severity levels are defined from 1 (lowest se-
verity) to 4 (highest). However, severity levels do not exist
for all DRGs and we used those proposed.
Sex, age and length of stay are mandatory data for
each discharge in the PMSI database.
Statistical analysis
PAH were identified according to the Weissman et al.
[4], Weissman modified by Gusmano et al. [43] and
Ansari et al. approaches [23]. In 2012, they were identi-
fied for the 98 French departments overall and for the
most frequent diagnosis groups. The proportion of PAH
was calculated by dividing the number of PAH by the
total number of hospital discharges in 2012. PAH crude
rates were calculated by dividing the number of PAH by
the 2011 national and departmental populations. Age-
and sex-standardised rates of PAH were calculated inNotes
J15.9, J16.8, J18.1, J18.8 In any diagnosis field, exclude cases with
secondary diagnosis of D57, and people under
2 months
, B16.9, B18.0, B18.1, In any diagnosis field
Principal diagnosis only
Principal diagnosis only, exclude cases with
procedure codes
.6, E10.7, E10.8, E11.0,
.6, E11.7, E11.8, E13.0,
.6, E13.7, E13.8, E14.0,
.6, E14.7, E14.8
In any diagnosis field
Principal diagnosis only, J20 only with diag2
of J41 J42 J43 J47 J44
Principal diagnosis only, exclude cases with
procedure codes
Principal diagnosis only





.6, K26.0, K26.1, K26.2,
.2, K27.4, K27.5, K27.6,
.6
Principal diagnosis only




K09.9, K12, K13 Principal diagnosis only
Principal diagnosis only
Principal diagnosis only
Table 3 Number of PAH in France in 2012 according to severity, type of event and diagnosis-related groups
Ansari approach Weissman approach p
N (%) N (%)
Diagnosis 1 (nervous system) 6,724 (1.3%) 455 (0.1%) <.001
group 2 (eye) 106 (0.0%) NA .
3 (ENT) 956 (0.2%) 5,262 (0.7%) .
4 (respiratory system) 211,490 (41.5%) 229,314 (30.9%) .
5 (circulatory system) 252,883 (49.6%) 288,396 (38.8%) .
6 (digestive system) 4,671 (0.9%) 50,947 (6.9%) .
7 (liver and pancreas) 1,927 (0.4%) NA .
8 (musculoskeletal system) 3,423 (0.7%) NA .
9 (skin) 6,568 (1.3%) 65,787 (8.9%) .
10 (endocrine and nutritional) 2,612 (0.5%) 20,807 (2.8%) .
11 (urinary system) 3,786 (0.7%) 79,428 (10.7%) .
12 (genital, male) 331 (0.1%) 4 (0.0%) .
13 (genital, female) 165 (0.0%) NA .
14 (obstetrics) 407 (0.1%) NA .
15 (childbirth) 143 (0.0%) 95 (0.0%) .
16 (haematology) 2,607 (0.5%) NA .
17 (haematology, others) 1,319 (0.3%) NA .
18 (infectious diseases) 2,125 (0.4%) 301 (0.0%) .
19 (psychiatry) 1,147 (0.2%) NA .
20 (psychiatry, organic) 329 (0.1%) NA .
21 (external causes) 754 (0.2%) NA .
22 (burns) 142 (0.0%) NA .
23 (other) 3,092 (0.6%) NA
25 (HIV) 1,040 (0.2%) 1,521 (0.2%) .
26 (polytrauma) 431 (0.1%) NA
27 (transplantations) 415 (0.1%) 157 (0.0%)
28 (very short stays) 613 (0.1%) 0
Type Surgical procedure 16,002 (3.1%) 98,545 (13.3%) <.001
Non-surgical procedure 24,753 (4.9%) 50,899 (6.9%) .
Medical stay 466,249 (91.4%) 592,961 (79.9%) .
Short stays 3,202 (0.6%) 69 (0.0%)
Severity 1 (low) 107,578 (21.1%) 229,912 (31.0%) <.001
2 150,140 (29.4%) 164,501 (22.2%) .
3 143,854 (28.2%) 174,614 (23.5%) .
4 (high) 34,814 (6.8%) 37,813 (5.1%)
Sex Male 269,771 (52.9%) 370,053 (49.8%) <.001
Female 240,435 (47.1%) 372,421 (50.16%) .
Age (yrs) (mean, SD) 72 (20) 61 (29) <.001
0-17 yr 21,142 (4.1%) 100,629 (13.6%) <.001
18-64 yr 111,164 (21.8%) 214,170 (28.9%)
65-74 yr 78,589 (15.4%) 90,402 (12.2%)
≥75. yr 299,311 (58.7%) 337,273 (45.4%)
Length of stay (days) (mean, SD) 9.6 (11.5) 7.3 (8.5) <.001
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Figure 1 Maps of standardised rate of PAH in French departments, 2012.
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method using the 2011 French population (Institut
National de la statistique et des etudes économiques -National Institute for statistics and economic studies:
http://www.insee.fr/fr/bases-dedonnees/default.asp?
page=recensement/resultats/2011/donnees-detaillees-
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INSEE)). The agreement between both approaches was
assessed graphically. The two approaches were compared
for diagnosis groups, type of stay, severity, sex, age and
length of stay. The characteristics of hospitalisations were
presented using median and range (or mean and SD) for
continuous variables and frequencies and proportions for
categorical variables. The methods were compared using
Student or Wilcoxon rank test for continuous variables
and Chi-square or Fisher test for categorical ones. Stat-
istical bilateral significance threshold was set at 5%.
Statistical analyses were performed using SAS version
9.1 (SAS Institute, Cary, North Carolina).
Results
PAH standardised rates in 2012
The total number of discharges in 2012 in France was
26,656,833. The number and proportion of PAH estimated
by the Weissman et al. and Ansari et al. approaches were,
respectively, 742,474 (2.8%) and 510,206 (1.9%) (Table 3
and Figure 1). Overall, 334,745 discharges were identified
by both approaches. The standardised rate of PAH esti-
mated by the Weissman and Ansari approaches were, re-
spectively, 13.3 and 9.0 cases per 1,000 inhabitants.
The characteristics of PAH are given in Table 3. There
was a significant correlation between diagnoses made by
the two approaches (Figure 2), and the two most common
causes of PAH (cardiovascular and respiratory systems) are
in the same ranking order. However, the Weissman et al.
approach identified a lower proportion of respiratory and
circulatory system conditions within PAH (38.9 and 30.9%
for Weissman and 49.6 and 41.5% for Ansari), and a higher
proportion of skin and urinary system conditions (8.9%
and 10.7% for Weissman and 1.3 and 0.7% for Ansari). Al-
though the highest percentage of PAH was found in sub-
jects over 75 years of age, the Weissman et al. approach
identified significantly older patients. The Weissman et al.Figure 2 Correlation between standardised rates of PAH in
France in 2012. Legend: Figure 2 shows the correlation between
age and sex-standardised rates of PAH measured by the Weissman
and Ansari approaches. Each dot represents a department.approach detects significantly shorter stays (7.3 ± 8.5 days
vs. 9.6 ± 11.5 days), with a lower severity level (p < 0.001)
and a lower proportion of medical stays (p < 0.01).
At the department level, the standardized rate of PAH
ranged from 4.9 to 11.8 cases per 1,000 inhabitants using
the Ansari method and from 8.8 to 15.0 cases per 1,000
inhabitants using the Weissman method. Figure 1 sug-
gests an overall North–south gradient, but there are sig-
nificant differences between the two approaches.
Discussion
Overall results
The estimation of PAH according to the Weissman et al.
and Ansari et al. approaches ranged from 2.8% of total dis-
charges to 1.9%. The standardised rate of PAH estimated
by the Weissman and Ansari approaches were, respect-
ively, 13.3 and 9.0 cases per 1,000 inhabitants. These re-
sults are consistent with the recent work of Gusmano
et al. that estimated standardized PAH rates between 9.1
and 11.1 per 1,000 inhabitants.
There are significant disparities by conditions groups,
age, length of stay, severity level, and proportion of med-
ical stays between the methods.
Strengths and limitations
This study is based on the nation-wide, all-payers, and
public and private hospitals discharge database. Hence it
can be considered as exhaustive and representative. By
definition, DRGs classify cases according to principal and
secondary diagnoses, patient age and sex, the presence of
co-morbidities and complications as well as the proce-
dures performed. The PMSI is based on DRGs allowing
an exhaustive patient case classification system (i.e. the
system of diagnosis-related groupings). The PMSI is stan-
dardized and exhaustive but there are some limitations.
Inconsistency may occur due to variability in coding in
different health institutions because of ignorance or misin-
terpretation of coding rules. Since 2009, army hospitals
have been included, and the definition of primary diagno-
sis has changed. The primary diagnosis is “the health
problem which motivated the admission of the patient,
determined at the end of the stay”.
In general, hospital discharges in European countries
tend to be related to the number of hospital beds in the
country [44]. Trends in hospital discharges may reflect
other independent causes. Healthcare demand grows as
population’s age. In the present study, PAH in subjects
over 65 years of age represent 67 to 72% according to
the algorithm. Changes in medical technologies and
medical practices are important.
The coding approaches may not be completely relevant
for the French population. Weissman et al. are still consid-
ered as the gold standard, even though many NCDs (e.g.
COPD) are not included. This is why we attempted to
Bourret et al. BMC Health Services Research  (2015) 15:4 Page 7 of 8compare results with a newer coding system used in the
Australian population which is close to the French popu-
lation but not completely identical. Moreover, some codes
are missing (e.g. J82, eosinophilic asthma). A new study is
favoured using an instrument specifically targeted to the
French population.
Generalizability
The discrepancies between the two coding approaches
are substantial. They may be, at least partly, explained
by various factors. Firstly, the two algorithms encompass
different disease categories. For instance, Weissman
et al. [5] take into account hypokalaemia and infec-
tious diseases which are two very common conditions.
Secondly, even when disease categories are labelled in
the same way, Ansari et al. [23] exclude a significant
proportion of hospitalisations as compared to Weissman
et al., due to a more restricted list of ICD codes, through
the exclusion of hospitalizations with surgical procedures.
Hence, though both methods include hypertension, Ansari
et al. coding [23] has fewer ICD-10 codes (2 vs. 15). The
Ansari method [23] is consequently more restrictive than
the Weissman method [5]. The restricted definition of the
Ansari method makes it closer to being “ambulatory care
sensitive” compared to the use of the broader definitions
of Weissman. However, the study was aimed at finding
differences and not at assessing the method of choice.
The results of the study using the Ansari et al. ap-
proach [23] are in line with data from many European
countries, with the highest rates for cardiovascular and
respiratory disorders. However, the rates vary widely de-
pending on the classification and coding methods.
In the Ansari et al. approach, respiratory diseases in-
clude communicable and non-communicable diseases
(asthma and COPD). The development of a coding exer-
cise is required before these two diseases are studied in
the French population.
Large differences exist between the 97 French Dépar-
tements. These may be due to variations in epidemio-
logical patterns, in coding practices, in medical practice
and in healthcare supply.
From a policy perspective, our study shows striking
differences between two published definitions of PAH.
On the one hand, some scholars have advocated that
each country develops its own method tailored to the
purpose [45]. On the other hand, implementing different
methods might prevent useful international compari-
sons. Nevertheless our study does not allow recom-
mending one method over the other.
Conclusion
There are significant differences between the Weissman
and Ansari methods with reference to potentially avoid-
able hospitalizations in France in 2012. The method usedto measure potentially avoidable hospitalizations is critical,
and might influence the assessment of accessibility and
performance of primary care.
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